WOLF — Grey Wolf Animal Health Income Statement
0.000.00%
- CA$46.50m
- CA$67.02m
- CA$26.83m
- 79
- 55
- 74
- 80
Annual income statement for Grey Wolf Animal Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 13.1 | 22.6 | 25.4 | 26.8 |
| Cost of Revenue | ||||
| Gross Profit | 7.15 | 11.6 | 12.8 | 13.8 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 13 | 23 | 23.9 | 24.9 |
| Operating Profit | 0.07 | -0.356 | 1.55 | 1.91 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -1.89 | 1.75 | 1.1 | 1.39 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.969 | 2.54 | 0.61 | 0.705 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.969 | 2.54 | 0.61 | 0.705 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.969 | 2.54 | 0.61 | 0.705 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.031 | 0.082 | 0.02 | 0.021 |
| Dividends per Share |